Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 16, 2014Current Pharmaceutical Design

Psoriasis and Vascular Risk: An Update

View Full Paper
Ask AI
Bookmark
Share

Authors

NKNiki KatsikiÇevre ve Şehircilik BakanlığıPAPanagiotis AnagnostisAristotle University of ThessalonikiVAVasilios G. AthyrosPreventive Cardiology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Katsiki et al. (2014) studied this question.

synapsesocial.com/papers/6a77dd4b576efb0ddaf7b16fhttps://doi.org/10.2174/1381612820666140417105323
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The association between psoriasis and dyslipidaemia: a systematic review2012 · 175 citations
  2. 2How to Identify Subjects with Poly-Vascular Disease?2012 · 13 citations
  3. 3Effect of Calcipotriol on Etanercept Partial Responder Psoriasis Vulgaris and Psoriatic Arthritis Patients2009 · 23 citations